Part of funding portal member: truCrowd, Inc.
Mobile Menu

AphriHelios Global, LLC

Leveraging Africa's low-production cost advantage to build a vertically integrated cannabis company bringing African and African diaspora brands to the world

Minimum target reached
Closed on 01/01/22


amount committed 

$10k - $107k

funding goal 

Regulation CF

exemption used 


pre money valuation 


min investment 



Security Type
Convertible Note
Annual Interest Rate: 8%
Discount Rate: 20%
Valuation Cap: $15M
Term: 2 years

Early Bird Bonus!

Investors who purchase the first 1,000 Units of Convertible Notes will receive an additional 15% Preferred Shares at conversion in a Qualified Equity Financing.


Volume Bonus!

Based on the size of your investment, you can also get bonus shares regardless of if you are an “early bird” investor or not! Early bird investors get both bonus percentages added together (an early bird investment of $5,000 would receive a 25% bonus, 10%+15%)

$5,000+ - 10% additional Conversion Shares
$10,000+ - 12.5% additional Conversion Shares
$20,000+ - 15% additional Conversion Shares
$50,000+ - 25% additional Conversion Shares

Who are we

AphriHelios seeks to become a pan-African, vertically integrated medicinal cannabis company by leveraging Africa’s, and particularly Lesotho’s, comparative advantage as a low-cost producer. Warm climates, rich soil, and a long history and expertise in agriculture mean parts of the African continent have the potential to be pivotal markets for cultivation.


The cannabis industry is exploding and is likely to grow even faster in the US as recent political shifts will likely lead to decriminalization and legalization at the federal level. This shift will open up the US market for AphriHelios to import, at scale, African-grown, high-quality, low-production-cost cannabis. 


AphriHelios will vertically integrate through a phased approach that allows the company to sustainably migrate down the value chain. The company will cement its position as a high-quality, low-cost producer while building an innovative and exciting product and brand platform that build brands and products around well-known cultural, social, sports, and entertainment influencers. 



Darin Hickman
Darin Hickman2 years ago

As our way of thanking our investors, we're launching Investor Perks:

Early Bird Perk

Investors who purchase the first 1,000 Units of Convertible Notes will receive an additional 15% Preferred Shares at conversion in a Qualified Equity Financing.

Volume Perks

$5,000 - $9,999 – 10% additional Preferred Shares at conversion in a Qualified Equity Financing

$10,000 - $19,999 – 12.5% additional Preferred Shares at conversion in a Qualified Equity Financing

$20,000 - $49,999 – 15% additional Preferred Shares at conversion in a Qualified Equity Financing

$50,000+ – 25% additional Preferred Shares at conversion in a Qualified Equity Financing

Load More


Unfortunately, this securities offering is closed. For questions, please email Thanks!

Tonny Sauls
Tonny Sauls - Investor2 years ago
Hi Darin

I have been trying to get hold of you since Monday through Forrest.

My company, Beloved Community Coalition Global Enterprises (Pty)Ltd, registered in the Republic of South Africa is ready to invest $1 000 (one thousand dollars) in the AphriHelios Crowd Fund.

Kindly advise how do I go about making the payment tranfer?

Sincerely regards

Tonny Sauls
Director: Beloved Community Global Enterprises (BeCoGE)
M: +27 76 109 6653
Darin Hickman
Darin Hickman - Issuer    
Hi Tonny, Given that the entity making the investment is an international company, you have two options. I will contact you now directly through your SA mobile number to discuss the best way forward.

2 years ago
Tion Allen-Thomas
Tion Allen-Thomas - Investor2 years ago
I have to ask this question. Where is this located? If it's in ghana I will consider this. I need more info on where this is located.
Darin Hickman
Darin Hickman - Issuer    
Hi Tion, Thank you for your question. Currently, we have a license to cultivate in Lesotho, and offices in Cape Town, South Africa, and Bethesda, Maryland. Given our pan-African focus, we have relationships in Ghana. Once we bed down our Lesotho operations, we will consider other African countries as their legal regimes evolve around cannabis.

2 years ago


Start-up Valuation Download
Offering Memorandum Download

Other Disclosures

Read the Form C filed with the SEC for other important disclosures, like financial statements, Directors, Officers, shareholders with more than 20% of voting rights, and more.
Special Note Regarding Forward-Looking Statements
This offering contains forward-looking statements within the meaning of the federal securities laws. We caution investors that any forward-looking statements presented in this offering, or which management may make orally or in writing from time to time, are based on the Company’s beliefs and assumptions made by, and information currently available to, the Company. When used, the words “anticipate,” “believe,” “expect,” “intend,” “may,” “might,” “plan,” “estimate,” “project,” “should,” “will,” “would,” “result” and similar expressions, which do not relate solely to historical matters, are intended to identify forward-looking statements. Such statements are subject to risks, uncertainties and assumptions and are not guarantees of future performance, which may be affected by known and unknown risks, trends, uncertainties and factors that are beyond the Company’s control. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or projected. While forward-looking statements reflect the Company’s good faith belief when made, they are not guarantees of future performance. The Company expressly disclaims any responsibility to update forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Moreover, we operate in a very competitive and rapidly changing environment, and new risks emerge from time to time. It is not possible to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this offering may not occur, and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. We undertake no obligation to revise or publically release the results of any revision to these forward-looking statements, except as required by law. Given these risks and uncertainties, prospective investors are cautioned not to place undue reliance on such forward-looking statements.

Back to top